Piddock L J, Jin Y F, Ricci V, Asuquo A E
Department of Infection, University of Birmingham, Edgbaston, UK.
J Antimicrob Chemother. 1999 Jan;43(1):61-70. doi: 10.1093/jac/43.1.61.
The accumulation of nalidixic acid and 14 fluoroquinolones over a range of external drug concentrations (10-100 mg/L; c. 25-231 microM) into intact cells of Escherichia coli KL-16, Staphylococcus aureus NCTC 8532, Pseudomonas aeruginosa NCTC 10662 and spheroplasts of E. coli was investigated. The effect of 100 microM carbonyl cyanide m-chlorophenyl hydrazone (CCCP) upon the concentration of quinolone accumulated by intact cells and spheroplasts of E. coli was also determined. Except for pefloxacin, there was an increase in the concentration of the six quinolones examined accumulated by E. coli, despite a reduction in fluorescence at alkaline pH. For ciprofloxacin the partition coefficient (P(app)) was constant despite an increase in the pH; however, the P(app) for nalidixic acid decreased significantly with an increase in pH. The concentration of nalidixic acid, ciprofloxacin and enrofloxacin accumulated by E. coli and S. aureus increased with an increase in temperature up to 40 degrees C and 50 degrees C, respectively. Above these temperatures the cell viability decreased. With an increase in drug concentration there was, for intact E. coli and 12/15 agents, and for S. aureus and 10/15 agents, a linear increase in the concentration of drug accumulated. However, for P. aeruginosa and 13/15 agents there was apparent saturation of an accumulation pathway. Assuming 100% accumulation into intact cells of E. coli, for 10/14 fluoroquinolones < or = 40% was accumulated by spheroplasts. CCCP increased the concentration of quinolone accumulated but the increase varied with the agent and the bacterial species. The variation in the effect of CCCP upon accumulation of the different quinolones into E. coli could result from chemical interactions or from different affinities of the proposed efflux transporter for each quinolone. Overall, these data suggest that accumulation of most quinolones into E. coli and S. aureus proceeds by simple diffusion, but that P. aeruginosa behaves differently.
研究了在一系列外部药物浓度(10 - 100 mg/L;约25 - 231 microM)下,萘啶酸和14种氟喹诺酮类药物在大肠杆菌KL - 16、金黄色葡萄球菌NCTC 8532、铜绿假单胞菌NCTC 10662的完整细胞以及大肠杆菌原生质体中的积累情况。还测定了100 microM羰基氰化物间氯苯腙(CCCP)对大肠杆菌完整细胞和原生质体积累喹诺酮类药物浓度的影响。除培氟沙星外,尽管在碱性pH下荧光降低,但所检测的六种喹诺酮类药物在大肠杆菌中积累的浓度有所增加。对于环丙沙星,尽管pH升高,分配系数(P(app))仍保持恒定;然而,萘啶酸的P(app)随pH升高而显著降低。大肠杆菌和金黄色葡萄球菌积累的萘啶酸、环丙沙星和恩诺沙星浓度分别在温度升高至40℃和50℃时增加。高于这些温度,细胞活力下降。随着药物浓度增加,对于完整的大肠杆菌和12/15种药物,以及金黄色葡萄球菌和10/15种药物,积累的药物浓度呈线性增加。然而,对于铜绿假单胞菌和13/15种药物,积累途径出现明显饱和。假设100%积累到大肠杆菌完整细胞中,对于10/14种氟喹诺酮类药物,原生质体积累量≤40%。CCCP增加了积累的喹诺酮类药物浓度,但增加幅度因药物和细菌种类而异。CCCP对不同喹诺酮类药物在大肠杆菌中积累的影响差异可能源于化学相互作用,或源于所提出的外排转运体对每种喹诺酮类药物的不同亲和力。总体而言,这些数据表明大多数喹诺酮类药物在大肠杆菌和金黄色葡萄球菌中的积累是通过简单扩散进行的,但铜绿假单胞菌的行为有所不同。